ESERX
Price
$34.63
Change
-$0.17 (-0.49%)
Updated
Aug 15 closing price
Net Assets
664.46M
VIGRX
Price
$237.87
Change
-$0.79 (-0.33%)
Updated
Aug 15 closing price
Net Assets
324.3B
Interact to see
Advertisement

ESERX vs VIGRX

Header iconESERX vs VIGRX Comparison
Open Charts ESERX vs VIGRXBanner chart's image
Eaton Vance Atlanta Capital Sel Eq R6
Price$34.63
Change-$0.17 (-0.49%)
VolumeN/A
Net Assets664.46M
Vanguard Growth Index Investor
Price$237.87
Change-$0.79 (-0.33%)
VolumeN/A
Net Assets324.3B
ESERX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ESERX vs. VIGRX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESERX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 324B vs. ESERX (664M). VIGRX pays higher dividends than ESERX: VIGRX (0.32) vs ESERX (0.00). ESERX was incepted earlier than VIGRX: ESERX (9 years) vs VIGRX (33 years). ESERX (0.75) is less costly to investors than VIGRX (0.17). VIGRX is a more actively managed with annual turnover of: 11.00 vs. ESERX (2.00). VIGRX has a lower initial minimum investment than ESERX: VIGRX (3000) vs ESERX (5000000). VIGRX annual gain was more profitable for investors over the last year : 24.03 vs. ESERX (-3.54). VIGRX return over 5 years is better than : 107.21 vs. ESERX (26.29).
ESERXVIGRXESERX / VIGRX
Total Expense Ratio0.750.17441%
Annual Report Gross Expense Ratio0.750.17441%
Fund Existence9 years33 years-
Gain YTD-4.20512.580-33%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets664M324B0%
Annual Yield % from dividends0.000.32-
Returns for 1 year-3.5424.03-15%
Returns for 3 years12.3673.6817%
Returns for 5 years26.29107.2125%
Returns for 10 yearsN/A321.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR27.260.57
+2.14%
Nektar Therapeutics
SUPN42.690.52
+1.23%
Supernus Pharmaceuticals
FTAI144.72-0.18
-0.12%
FTAI Aviation Ltd
SBFM1.49-0.02
-1.33%
Sunshine Biopharma Inc
AXTI2.05-0.11
-5.09%
AXT